Skip to main content

Eva Sanz Sapera

Institutions of which they are part

Predoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Eva Sanz Sapera

Institutions of which they are part

Predoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Related news

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

Related professionals

Arnau Hervera Abad

Arnau Hervera Abad

Main researcher
Clinical Neuroimmunology
Read more
Cristina de Dios Conde

Cristina de Dios Conde

Tècnic/a Superior Recerca
High Technology Unit (UAT)
Preclinical Core Facilities
External Strategy Directorate
Read more
Shirley Guzmán Avilés

Shirley Guzmán Avilés

Tècnic/a Grau Superior
External Strategy Directorate
Read more
Carolina Maldonado Toral

Carolina Maldonado Toral

Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.